FdaApplication
BLA 761309
Identifiers
- fda_app_no: BLA761309
Properties
| Property | Value |
|---|---|
| applicant_name | Genentech, Inc. |
| application_type | BLA |
| approval_date | 2023-06-15 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| COLUMVI | GLOFITAMAB-GXBM | 10MG/10ML (1MG/ML) | Injection |
| COLUMVI | GLOFITAMAB-GXBM | 2.5MG/2.5ML (1MG/ML) | Injection |
2 products